Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.
Saved in:
| Title: | Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness. |
|---|---|
| Authors: | Wang Y; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Bukkems LH; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Ter Heine R; Department of Pharmacy, Pharmacology and Toxicology, Radboudumc, Nijmegen, The Netherlands., van Hasselt JGC; Leiden Academic of Drug Research, Leiden, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Hendrikx JJMA; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., Van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Becker A; Department of Pulmonology, Amsterdam University Medical Center, Amsterdam, The Netherlands., van den Heuvel MM; Department of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands., Theelen WSME; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Oude Munnink TH; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands., Smit EF; Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. d.j.a.r.moes@lumc.nl. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2026 Apr; Vol. 65 (4), pp. 621-632. Date of Electronic Publication: 2026 Jan 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41524895 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bukkems+LH%22">Bukkems LH</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ter+Heine+R%22">Ter Heine R</searchLink>; Department of Pharmacy, Pharmacology and Toxicology, Radboudumc, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Hasselt+JGC%22">van Hasselt JGC</searchLink>; Leiden Academic of Drug Research, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koolen+SLW%22">Koolen SLW</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hendrikx+JJMA%22">Hendrikx JJMA</searchLink>; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Van+der+Hulle+T%22">Van der Hulle T</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kapiteijn+E%22">Kapiteijn E</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zwaveling+J%22">Zwaveling J</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Becker+A%22">Becker A</searchLink>; Department of Pulmonology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Heuvel+MM%22">van den Heuvel MM</searchLink>; Department of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Theelen+WSME%22">Theelen WSME</searchLink>; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Oude+Munnink+TH%22">Oude Munnink TH</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Smit+EF%22">Smit EF</searchLink>; Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Guchelaar+HJ%22">Guchelaar HJ</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Moes+DJAR%22">Moes DJAR</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. d.j.a.r.moes@lumc.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227606849%22">Clinical pharmacokinetics</searchLink> [Clin Pharmacokinet] 2026 Apr; Vol. 65 (4), pp. 621-632. <i>Date of Electronic Publication: </i>2026 Jan 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22%22"> </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7606849 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1926 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203125963%22">03125963 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacokinet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41524895 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40262-025-01610-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 621 Titles: – TitleFull: Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Bukkems LH – PersonEntity: Name: NameFull: Ter Heine R – PersonEntity: Name: NameFull: van Hasselt JGC – PersonEntity: Name: NameFull: Koolen SLW – PersonEntity: Name: NameFull: Hendrikx JJMA – PersonEntity: Name: NameFull: Van der Hulle T – PersonEntity: Name: NameFull: Kapiteijn E – PersonEntity: Name: NameFull: Zwaveling J – PersonEntity: Name: NameFull: Becker A – PersonEntity: Name: NameFull: van den Heuvel MM – PersonEntity: Name: NameFull: Theelen WSME – PersonEntity: Name: NameFull: Oude Munnink TH – PersonEntity: Name: NameFull: Smit EF – PersonEntity: Name: NameFull: Guchelaar HJ – PersonEntity: Name: NameFull: Moes DJAR IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1926 Numbering: – Type: volume Value: 65 – Type: issue Value: 4 Titles: – TitleFull: Clinical pharmacokinetics Type: main |
| ResultId | 1 |